Mark Hyman, MD · 2025-07-23 · Mark Hyman (host), Eric Topol

Alzheimer's Starts 20 Years Before You Notice It — Here's What to Do Now

56 research-tied claims examined: 2 contradicted 9 overstated 3 context 36 supported 6 unverified

2

Contradicted by research

0:32:13Mark Hyman (host)contradictedmoderate

Diets with high protein intake, particularly from animal sources, promote atherosclerosis and induce systemic inflammation.

"we've seen studies after study that show too high a protein diet, particularly animal protein, can induce, promote atherosclerosis. That's the last thing we want, right? It's pro-inflammatory." (said at 0:32:13)

Comprehensive systematic reviews and meta-analyses of prospective cohort studies and randomized controlled trials do not support the claim that high protein intake or animal protein promotes atherosclerosis or increases cardiovascular disease (CVD) risk. An umbrella review published by the German Nutrition Society found probable evidence for an absence of association between total, animal, or plant protein intake and coronary heart disease (CHD). Similarly, large meta-analyses of prospective cohorts found no significant association between total or animal protein intake and risk of CHD, hypertension, or cardiovascular mortality. In randomized trials, higher protein diets have been associated with improvements in blood pressure and vascular endothelial function (flow-mediated dilation).

0:43:55Eric Topolcontradictedhigh

On the Horvath epigenetic clock, the only two interventions demonstrated to decrease biological aging are exercise and GLP-1 receptor agonist drugs.

"Steve Horvath, who had came up with the Horvath clock, we were talking about that epigenetic— The only two things so far— —that have decreased biologic aging from that clock are exercise and then more recently the GLP-1 drugs." (said at 0:43:55)

The claim that exercise and GLP-1 receptor agonists are the only two interventions shown to reduce biological age on the Horvath epigenetic clock is contradicted by published interventional studies, including studies co-authored by Steve Horvath himself. The TRIIM trial (Fahy et al., 2019) demonstrated a mean 1.5-year reversal of epigenetic age using a cocktail of recombinant human growth hormone, DHEA, and metformin evaluated on the Horvath clock along with three other DNA methylation clocks. Additionally, randomized controlled pilot trials evaluating multimodal dietary and lifestyle modifications (e.g., Fitzgerald et al., 2021) and studies on ketogenic dietary interventions (e.g., Crujeiras et al., 2025) have reported significant reductions in Horvath DNAmAge. Systematic reviews of epigenetic age modifying interventions also document multiple lifestyle, dietary, and pharmacological strategies beyond exercise and GLP-1 agonists that lower biological age across various epigenetic clocks.

Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.